Better Health,
Brighter Future
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download
Data Book
Click to download
For Investors & Analysts
Earnings Release Presentation
Committed to Bringing Better Health and a Brighter Future to People Worldwide
Click to download
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Audio Conference Call 6:00pm-7:15pm (Call 1: Presentation and Q&A Session)
Audio Conference Call 9:30pm-10:30pm (Call 2: Q&A Session only)
For Media
Earnings Release Presentation
Click to download
Audio Conference Call 4:45pm-5:30pm (Presentation and Q&A Session)
Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download
Press Release
Data Book
Click to download
Earnings Release Presentation
CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q3
Costa Saroukos, Chief Financial Officer
Click to download
Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download
Financial FAQs regarding FY2019 Q3 earnings
Click to download
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download
Press Release
Data Book
Click to download
Supplementary materials for Data Book
Click to download
Earnings Release Presentation
For Investors and Analysts
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download
For Media
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download
Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download
Financial FAQs regarding FY2019 Q2 earnings
Click to download
On-demand Webcast (Earnings meeting: For Investors & Analysts: 5:45pm-7:00pm JST)
On-demand Audio (Conference call 9:00pm-9:45pm JST)
Partial Correction of Financial Statements submitted to TSE (Tokyo Stock Exchange)
Click to download
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download
Press Release
Data Book
Click to download
Earnings Release Presentation
CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q1
Costa Saroukos, Chief Financial Officer
Click to download
Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download
Financial FAQs regarding FY2019 Q1 earnings
Click to download